nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors (vol 39, pg 3660, 2021)
A. J. Wagner,V Ravi,R. F. Riedel,K. Ganjoo,B. A. Van Tine,R. Chugh,L. Cranmer,E. M. Gordon,J. L. Hornick,H. Du,B. Grigorian,A. N. Schmid,S. Hou,K. Harris,D. J. Kwiatkowski,N. P. Desai,M. A. Dickson
